Finance

Lists
600488:SHA
Jinyao Pharmaceutical Co Ltd
CNÂ¥5.31
+1.92%
(+0.100) 1D
Sep 8, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600488...
Open
CNÂ¥5.21
High
CNÂ¥5.32
Low
CNÂ¥5.16
Mkt. cap
5.69B
Avg. vol.
86.16M
Volume
36.76M
Dividend
0.98%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 14, 2026
P/E ratio
89.98
52-wk high
CNÂ¥8.44
52-wk low
CNÂ¥3.68
EPS
CNÂ¥0.06
Shares outstanding
1.09B
No. of employees
3K
Open
CNÂ¥5.21
High
CNÂ¥5.32
Low
CNÂ¥5.16
Mkt. cap
5.69B
Avg. vol.
86.16M
Volume
36.76M
Dividend
0.98%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 14, 2026
P/E ratio
89.98
52-wk high
CNÂ¥8.44
52-wk low
CNÂ¥3.68
EPS
CNÂ¥0.06
Shares outstanding
1.09B
No. of employees
3K
About Jinyao Pharmaceutical Co Ltd
CEO-
Employees2.73K
Founded1939
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
643.16M
676.50M
608.11M
704.94M
Cost of goods sold
354.82M
483.21M
352.88M
415.71M
Cost of revenue
354.82M
483.21M
352.88M
415.71M
Research and development expenses
28.15M
38.57M
22.32M
25.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.01M
187.11M
177.46M
169.79M
Operating expense
213.47M
232.54M
202.12M
197.08M
Total operating expenses
568.29M
715.75M
554.99M
612.78M
Operating income
74.87M
-39.25M
53.12M
92.16M
Other non operating income
-69.26M
69.08M
-4.08M
-12.80M
EBT including unusual items
28.00M
-6.06M
21.61M
45.72M
EBT excluding unusual items
1.87M
21.61M
45.73M
82.59M
Income tax expense
82.22K
-15.82M
6.36M
9.57M
Effective tax rate
0.29%
261.02%
29.41%
20.92%
Other operating expenses
2.91M
7.48M
1.44M
2.76M
Net income
20.24M
1.02M
13.89M
29.28M
Net profit margin
3.15%
0.15%
2.28%
4.15%
Earnings per share
-
-
-
-
Interest and investment income
1.71M
507.17K
1.53M
4.84M
Interest expense
-5.03M
-5.14M
-4.84M
-1.53M
Net interest expenses
-3.32M
-4.63M
-3.31M
3.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
147.15M
33.12M
125.49M
163.34M
Gain or loss from assets sale
-9.24K
-404.02K
-
417.62K
AI content may include mistakes. Learn more
Google apps